De Lemos M.L.
121
Coauthors
15
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neurología | 10 |
| Neuropsicología | 5 |
| Inmunología | 2 |
| Biología | 2 |
| Biología molecular | 2 |
| Biología celular | 1 |
| Genética | 1 |
| Bioquímica | 1 |
| Medicina interna | 1 |
| Inflamación | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 13 |
| Fisiología humana | 9 |
| Farmacología y terapéutica | 4 |
| Bioquímica | 3 |
| Fisiología y materias afines | 2 |
| Ginecología, obstetricia, pediatría, geriatría | 2 |
| Sistemas fisiológicos específicos de los animales | 2 |
| Ciencias de la computación | 1 |
| Microorganismos, hongos y algas | 1 |
| Problemas sociales y servicios a grupos | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 15 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Antoni Camins | 15 |
| Auladell C. | 14 |
| Pallás M. | 12 |
| Junyent F. | 10 |
| Folch J. | 10 |
| Verdaguer E. | 8 |
| Romero R. | 7 |
| Zárate C.B. | 7 |
| Utrera J. | 4 |
| Petrov D. | 4 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Tau hyperphosphorylation and axonal damage induced by N,N- diethyldithiocarbamate (DEDTC) treatment along late postnatal development is followed by a rescue during adulthood
ArticleAbstract: Axonal degeneration has been described as the pathological hallmark of peripheral neuropathies inducPalabras claves:Axonal damage, DEDTC, Postnatal development, Tau phosphorylationAutores:Antoni Camins, Auladell C., De Lemos M.L., Junyent F., Pallás M., Romero R., Utrera J.Fuentes:scopusTaurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain
ArticleAbstract: Taurine, 2-aminoethanesulfonic acid, is present at high concentrations in many invertebrate and vertPalabras claves:Calbindin D28k, Calretinin, CAMKII, Parvalbumin, taurineAutores:Antoni Camins, Auladell C., De Lemos M.L., Junyent F., Pallás M., Romero R., Utrera J.Fuentes:scopusDecrease of calbindin-d28k, calretinin, and parvalbumin by taurine treatment does not induce a major susceptibility to kainic acid
ArticleAbstract: Taurine, 2-aminoethanesulfonic acid, is present at high concentrations in many invertebrate and vertPalabras claves:calcium, Epilepsy, neuronal death, neuroprotectionAutores:Antoni Camins, Auladell C., De Lemos M.L., Junyent F., Pallás M., Porquet D., Romero R., Utrera J.Fuentes:scopusLack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid
ArticleAbstract: Aims: 3-Nitropropionic acid (3-NP) is a toxin that replicates most of the clinical and pathophysioloPalabras claves:Huntington, JNK3, Neurodegeneration, Nitropropionic acidAutores:Antoni Camins, Auladell C., De Lemos M.L., Folch J., Junyent F., Pallás M., Verdaguer E., Zárate C.B.Fuentes:scopusVulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis
ArticleAbstract: The pathogenesis of Alzheimer disease (AD) is characterized by accumulation of β-amyloid protein inPalabras claves:Alzheimer disease, APPswe/PS1dE9 mouse, Calbindin, Calretinin, hippocampus, ParvalbuminAutores:Antoni Camins, Auladell C., Brox S., De Lemos M.L., Olloquequi J., Petrov D., Romero R., Verdaguer E.Fuentes:scopus